Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ian Ford

Showing results (151-160 of 508) with videos related to

Pageof 51
Sort By:
ESC Heart Failure|March 29, 2024
Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fractionKieran F Docherty, John J V McMurray, Paul R Kalra, et al.
The American Journal of Cardiology|May 20, 2021
Prevalence, Incidence and Prognostic Implications of Left Bundle Branch Block in Patients with Chronic Coronary Syndromes (From the CLARIFY Registry)Arthur Darmon, Gregory Ducrocq, Yedid Elbez, et al.
BMJ Open|August 27, 2021
SurgiCal Obesity Treatment Study (SCOTS): a prospective, observational cohort study on health and socioeconomic burden in treatment-seeking individuals with severe obesity in Scotland, UKRuth M Mackenzie, Nicola Greenlaw, Abdulmajid Ali, et al.
Diabetes|April 30, 2002
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention StudyDilys J Freeman, John Norrie, Muriel J Caslake, et al.
Journal of Lipid Research|July 7, 2009
Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trialNirupa R Matthan, Nancy Resteghini, Michele Robertson, et al.
Current Medical Research and Opinion|October 14, 2016
Financial impact of ivabradine on reducing heart failure penalties under the Hospital Readmission Reduction ProgramAnuraag R Kansal, Stanimira Krotneva, Ali Tafazzoli, et al.
Journal of the American College of Cardiology|December 24, 2016
High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart DiseaseIan Ford, Anoop S V Shah, Ruiqi Zhang, et al.
Circulation|November 18, 2009
Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart diseaseStuart Watkins, Ross McGeoch, Jonathan Lyne, et al.
Annals of Surgery|April 5, 2003
Local or general anesthesia for open hernia repair: a randomized trialPatrick J O'Dwyer, Michael G Serpell, Keith Millar, et al.
Diabetes|October 27, 2004
Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention studyNaveed Sattar, Olga Scherbakova, Ian Ford, et al.
Pageof 51

Showing results (151-160 of 508) with videos related to

Sort By:
Pageof 51
ESC Heart Failure|March 29, 2024
Intravenous iron and SGLT2 inhibitors in iron-deficient patients with heart failure and reduced ejection fractionKieran F Docherty, John J V McMurray, Paul R Kalra, et al.
The American Journal of Cardiology|May 20, 2021
Prevalence, Incidence and Prognostic Implications of Left Bundle Branch Block in Patients with Chronic Coronary Syndromes (From the CLARIFY Registry)Arthur Darmon, Gregory Ducrocq, Yedid Elbez, et al.
BMJ Open|August 27, 2021
SurgiCal Obesity Treatment Study (SCOTS): a prospective, observational cohort study on health and socioeconomic burden in treatment-seeking individuals with severe obesity in Scotland, UKRuth M Mackenzie, Nicola Greenlaw, Abdulmajid Ali, et al.
Diabetes|April 30, 2002
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention StudyDilys J Freeman, John Norrie, Muriel J Caslake, et al.
Journal of Lipid Research|July 7, 2009
Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trialNirupa R Matthan, Nancy Resteghini, Michele Robertson, et al.
Current Medical Research and Opinion|October 14, 2016
Financial impact of ivabradine on reducing heart failure penalties under the Hospital Readmission Reduction ProgramAnuraag R Kansal, Stanimira Krotneva, Ali Tafazzoli, et al.
Journal of the American College of Cardiology|December 24, 2016
High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart DiseaseIan Ford, Anoop S V Shah, Ruiqi Zhang, et al.
Circulation|November 18, 2009
Validation of magnetic resonance myocardial perfusion imaging with fractional flow reserve for the detection of significant coronary heart diseaseStuart Watkins, Ross McGeoch, Jonathan Lyne, et al.
Annals of Surgery|April 5, 2003
Local or general anesthesia for open hernia repair: a randomized trialPatrick J O'Dwyer, Michael G Serpell, Keith Millar, et al.
Diabetes|October 27, 2004
Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention studyNaveed Sattar, Olga Scherbakova, Ian Ford, et al.
Pageof 51